LTR Pharma Limited (ASX:LTP)
0.405
-0.025 (-5.81%)
At close: Apr 28, 2026
LTR Pharma Market Cap
LTR Pharma has a market cap or net worth of 73.62 million as of April 28, 2026. Its market cap has increased by 14.59% in one year.
Market Cap
73.62M
Enterprise Value
47.84M
Revenue
1.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
Market Cap Chart
Since December 11, 2023, LTR Pharma's market cap has increased from 52.98M to 73.62M, an increase of 38.96%. That is a compound annual growth rate of 14.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 73.62M | -43.71% |
| Dec 31, 2025 | 130.78M | -10.78% |
| Dec 31, 2024 | 146.59M | 204.77% |
| Dec 29, 2023 | 48.10M | -9.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cynata Therapeutics | 80.73M |
| Radiopharm Theranostics | 74.43M |
| Amplia Therapeutics | 84.66M |
| Paradigm Biopharmaceuticals | 85.84M |
| Botanix Pharmaceuticals | 87.05M |
| Arovella Therapeutics | 92.47M |
| Neurizon Therapeutics | 62.34M |
| Immutep | 104.63M |